In vitro blood and fibroblast responses to BisGMA–TEGDMA/bioactive glass composite implants

This in vitro study was designed to evaluate both blood and human gingival fibroblast responses to bisphenol A–glycidyl methacrylate–triethyleneglycol dimethacrylate (BisGMA–TEGDMA)/bioactive glass (BAG) composite, aimed to be used as composite implant abutment surface modifier. Three different type...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of materials science. Materials in medicine 2014, Vol.25 (1), p.151-162
Hauptverfasser: Abdulmajeed, Aous A., Kokkari, Anne K., Käpylä, Jarmo, Massera, Jonathan, Hupa, Leena, Vallittu, Pekka K., Närhi, Timo O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This in vitro study was designed to evaluate both blood and human gingival fibroblast responses to bisphenol A–glycidyl methacrylate–triethyleneglycol dimethacrylate (BisGMA–TEGDMA)/bioactive glass (BAG) composite, aimed to be used as composite implant abutment surface modifier. Three different types of substrates were investigated: (a) plain polymer (BisGMA 50 wt%–TEGDMA 50 wt%), (b) BAG–composite (50 wt% polymer + 50 wt% fraction of BAG–particles,
ISSN:0957-4530
1573-4838
DOI:10.1007/s10856-013-5040-0